CPF Texas’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

CPF Texas’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-4,395	Closed	-$189K	–	275
2018 Q2	$189K	Buy	+4,395	New	+$185K	0.1%	141
2018 Q1	–	Sell	-22	Closed	-$1K	–	291
2017 Q4	$1K	Buy	+22	New	+$936	﹤0.01%	265

Other funds holding XPH

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

CPF Texas's XPH Position: Q3 2018 in Review

CPF Texas sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q3 2018, closing a stake of 4,395 shares — an estimated $189K sold.

CPF Texas first reported a position in XPH in Q4 2017 and held it in 2 quarters. The position peaked at $189K in Q2 2018. 85 funds tracked by Wall St. Rank hold XPH as of Q3 2018.

CPF Texas reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q3 2018 after selling out during the quarter.
CPF Texas sold 4,395 State Street SPDR S&P Pharmaceuticals ETF shares in Q3 2018, an estimated $189K.
CPF Texas first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2017 and held it in 2 quarters.
CPF Texas's State Street SPDR S&P Pharmaceuticals ETF position peaked at $189K in Q2 2018.
85 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2018.

Based on CPF Texas's 13F filing for Q3 2018, filed 14 Nov 2018.